News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Neeraj Agarwal Congratulated Michael Ong and Soumyajit Roy on ASCO 2025 Abstract
Neeraj Agarwal, Michael Ong and Soumyajit Roy
May 30, 2025, 20:45

Neeraj Agarwal Congratulated Michael Ong and Soumyajit Roy on ASCO 2025 Abstract

Neeraj Agarwal, Professor of Medicine and a Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute (HCI), shared a post X:

“Congrats Michael Ong, Soumyajit Roy for oral  Abstract 5002 at ASCO 25.
Real-world IRONMAN registry of mHSPC prostate cancer (n=1288 pts).
PSA<0.02 after 6-12 months of prescription had best prognosis (3-yr OS 92.7%)”
Michael Ong

Title: Prognostic significance of PSA>0.2 after 6-12 months treatment for metastatic hormone-sensitive prostate cancer (mHSPC) intensified by androgen-receptor pathway inhibitors (ARPI): A multinational real-world analysis of the IRONMAN registry.

Journal: ASCO

Authors: Michael Ong, Soumyajit Roy, Kim Chi, Tanya Dorff, Sebastien Hotte, Alexander Wyatt, Lauren Howard, Karen Autio, Deborah Enting, Aurelius Omlin, Joaquin Mateo, Raymond McDermott, Ian Davis, Anders Bjartell, Laurel Cannon, Alyssa Chan-Cuzydlo, Philip Kantoff, Lorelei Mucci, Daniel George

Read the full abstract.

Michael Ong

More posts featuring Neeraj Agarwal on OncoDaily.

Alexander Wyatt Alyssa Chan-Cuzydlo Anders Bjartell Aurelius Omlin cancer Daniel George Deborah Enting Huntsman Cancer Institute Ian Davis Joaquin Mateo Karen Autio Kim Chi Laurel Cannon Lauren Howard Lorelei Mucci mHSPC Michael Ong Neeraj Agarwal OncoDaily Oncology Philip Kantoff prostate cancer PSA Raymond McDermott Sebastien Hotte Soumyajit Roy Tanya Dorff
Special Coverage
Voices
Aug 21, 2025, 19:28
Parvati Tiwari: Advocates Express Alarm Over NCI’s Decision to End PBTC Funding for Pediatric Brain Tumor Trials
Voices
Aug 21, 2025, 15:59
George Kumar: The interplay Between Cardiovascular Disease (CVD) and Cancer
Voices
Aug 21, 2025, 15:47
European Society of Gynaecological Oncology Announces that Applications are Open for Editor-in-Chief of IJGC
Insight
Aug 21, 2025, 15:37
Carolina Reduzzi: ctDNA Landscape Analysis Post CDK4/6 Inhibitor in HR+/HER2- Metastatic Breast Cancer
Voices
Aug 21, 2025, 15:30
Clinician-Scientists Awarded NMRC Transition Awards for Precision Lung Cancer Research - National Cancer Centre Singapore
Voices
Aug 21, 2025, 15:22
Construction of the $658 million Sydney Children’s Hospital Stage One and MCCCC Project Has Reached Completion
Oncolibrary
Aug 21, 2025, 15:00
Breakthrough Emactuzumab Phase 3 TANGENT Trial in TGCT: SynOx Pharma Reports Enrollment Completed Ahead of Schedule
Voices
Aug 21, 2025, 14:50
Andrea Apolo Highlights the Top 5 Clinical Advances in Bladder Cancer Treatment for 2024
Insight
Aug 21, 2025, 14:47
Loay Kassem: Study Reveals BRCA Mutation Rates in Egyptian Women with Breast or Ovarian Cancer
Insight
Aug 21, 2025, 14:41
Tiago Cordeiro Felismino: Exploring the Role of Neutrophil-to-Lymphocyte Ratio in Advanced HCC Treatment
Voices
Aug 21, 2025, 14:40
Larissa Nekhlyudov Celebrates Leadership of Emily Smith Tonorezos and Michelle Mollica in Cancer Survivorship
Voices
Aug 21, 2025, 14:32
Hayley Jones: McCabe Centre Supports Daffodil Day with 38,000 Daffodils for Cancer Awareness